Publication: Advancing natural killer therapies against cancer

Publié dans: Cell, 2022, 185 (9), pp.1451-1454. ⟨10.1016/j.cell.2022.04.006⟩

Auteurs: Emilie Narni-Mancinelli, Eric Vivier

Résumé

Natural killer (NK)-based therapies against cancer are emerging, but the understanding of NK cell functions needs to be completed to optimize these treatments. In this issue, Pan et al. (2022) show that pro-apoptotic molecules, such as BH3-mimetics, synergize with NK cells to induce mitochondria-driven apoptosis in tumor cells, thereby enhancing the efficacy of NK cell therapies.

Lien vers Pubmed [PMID] – 35487189

Lien vers HAL – amu-03982941

Lien vers le DOI – 10.1016/j.cell.2022.04.006